Enhanced Quitline Support for Smoking Cessation
(CONNECT Trial)

Recruiting in Palo Alto (17 mi)

Overseen bySteffani Bailey

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: OHSU Knight Cancer Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, smoking cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase smoking cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged smokers.

Research Team

Steffani Bailey

Principal Investigator

OHSU Department of Family Medicine

Eligibility Criteria

This trial is for adult tobacco users (18+) who have visited eligible study clinics in Oregon during a 24-month period. Participants must be willing to recruit a clinic champion and manager, agree to randomization, and their clinic should use the OCHIN Epic EHR system for at least one year.

Inclusion Criteria

Study Patient: Identified as current tobacco users during >= 1 ambulatory and/or telehealth visit to one of the eligible study clinics over the 24-month study period

Study Clinic: Willing to recruit a provider to serve as a clinic champion and a clinic manager

Study Clinic: On the OCHIN Epic EHR for >= 1 year

See 3 more

Treatment Details

Interventions

Enhanced Academic Detailing (Behavioral Intervention)
Informational Intervention (Behavioral Intervention)

Trial OverviewThe trial tests an electronic Quitline referral system with enhanced academic detailing to see if it helps more people quit smoking. It compares how effective this strategy is against usual care in community health centers, also looking into its cost-effectiveness.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: ARM II (Quitline eReferral plus enhanced AD)Experimental Treatment2 Interventions

Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

Group II: Arm I (Quitline eReferral)Active Control1 Intervention

Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.